fda ends semaglutide shortage The Ozempic Is Over Novo asks FDA to bar

This study showed that use of GLP-1 RAs was not associated with increased incidence of suicide or suicide attempts in either the active comparator new-user design or in the self-controlled case series design

Recently, it has come to light that using Ozempic can result in a serious, debilitating medical condition known as gastroparesis or stomach paralysis

Smart insulin and closed-loop systems On the insulin side, research is advancing toward glucose-responsive insulin formulations that would automatically adjust their activity based on blood sugar levels, essentially building in the safety feature that GLP-1 drugs inherently have

Using our state-of-the-art facilities, we precisely measure and prepare all components

doi: 10.1200/JCO.2025.43.16_suppl.10535